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Background: Burkholderia pseudomallei (Bp), a Gram-negative, motile, facultative intracellular bacterium is the
causative agent of melioidosis in humans and animals. The Bp genome encodes a repertoire of virulence factors,
including the cluster 3 type III secretion system (T3SS-3), the cluster 1 type VI secretion system (T6SS-1), and the
intracellular motility protein BimA, that enable the pathogen to invade both phagocytic and non-phagocytic cells. A
unique hallmark of Bp infection both in vitro and in vivo is its ability to induce cell-to-cell fusion of macrophages to
form multinucleated giant cells (MNGCs), which to date are semi-quantitatively reported following visual inspection.
Results: In this study we report the development of an automated high-content image acquisition and analysis
assay to quantitate the Bp induced MNGC phenotype. Validation of the assay was performed using T6SS-1 (Δhcp1)
and T3SS-3 (ΔbsaZ) mutants of Bp that have been previously reported to exhibit defects in their ability to induce
MNGCs. Finally, screening of a focused small molecule library identified several Histone Deacetylase (HDAC) inhibitors
that inhibited Bp-induced MNGC formation of macrophages.
Conclusions: We have successfully developed an automated HCI assay to quantitate MNGCs induced by Bp in
macrophages. This assay was then used to characterize the phenotype of the Bp mutants for their ability to induce
MNGC formation and identify small molecules that interfere with this process. Successful application of chemical
genetics and functional reverse genetics siRNA approaches in the MNGC assay will help gain a better understanding of
the molecular targets and cellular mechanisms responsible for the MNGC phenotype induced by Bp, by other bacteria
such as Mycobacterium tuberculosis, or by exogenously added cytokines.
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Burkholderia pseudomallei (Bp) is a Gram-negative bac-
terial pathogen and the causative agent of melioidosis, a
potentially fatal disease if misdiagnosed or left untreated
[1,2]. Bp is endemic to Southeast Asia, Northern Australia,
South America, Africa, Middle East, China and India and
the pathogen can be commonly isolated from soil and
surface waters [1,3,4]. Both acute and chronic infections* Correspondence: rekha.g.panchal.civ@mail.mil
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unless otherwise stated.with Bp can be acquired by inhalation, percutaneous inocu-
lation and in rare circumstances by ingestion. The clinical
symptoms of melioidosis are broad and may present as
acute or chronic pneumonia, internal organ abscesses (lung,
liver and spleen), fulminating septicemia and uncommonly
individuals can be asymptomatic [1]. In fact, and due to the
facultative intracellular lifestyle of Bp, dormant cases have
been reported with the most notable being 62 years after
initial exposure [5]. With the relative ease of genetic ma-
nipulation, environmental availability and intrinsic anti-
biotic resistance, Bp is listed as a category B select agent by
the U.S. Centers for Disease Control and Prevention [6].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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http://www.biomedcentral.com/1471-2180/14/98Macrophages and monocytes play critical roles in both
the innate and adaptive arms of the immune system and
are the first line of host defense mediating immunological
responses to foreign antigens [7,8]. These cells have
diverse functions within the host including phagocytosis
of bacterial, fungal, parasitic and viral pathogens, cytokine
and chemokine biosynthesis for inflammatory mediated
responses to invading pathogens as well as regulation of
cellular metabolic processes including fatty acid metabol-
ism, iron reprocessing and mineral reabsorption [9-11]. In
response to certain biological triggers, monocytes or mac-
rophages form multinucleated giant cells (MNGCs), which
involves the fusion of adjacent cells and results in a multi-
nucleated cell with a single cytoplasmic compartment
[12]. MNGCs are a well characterized phenotype in tissue
granuloma formation in response to bacterial infection,
with the most notable being associated with Mycobacterium
tuberculosis (Mtb). Using various animal, human, in vitro
cell culture and explant tissue models of Mtb infection it
has been demonstrated that monocytes develop into various
MNGC types, which is essential in the confinement of Mtb
within infectious granulomas [13-20]. Likewise, mono-
cyte and macrophage MNGC formation can be induced
in vitro using various conditioned mediums containing
exogenous cytokines, lectin, phorbol myristate acetate
and even select antibodies [21-32]. The most notable
cytokines associated with monocyte and macrophage
differentiation into MNGCs are Interleukin-4 (IL-4) and
Interferon gamma (IFN-γ). However, recent reports have
also demonstrated that MNGC formation is dependent
on diverse range of cellular proteins including CD36,
TREM-2, E-cadherin, CCL2 and Rac1, MMP9, DC-
STAMP, E-cadherin and Syk; all of which are involved in
intracellular signaling, cell surface communication, prote-
olysis, chemotaxis and cellular transcription [28,33-43].
A unique phenotypic characteristic of Bp infection, in
addition to Burkholderia mallei (Bm) and Burkholderia
thailandensis (Bt), is the ability to induce host cell MNGC
formation following cellular uptake, in both tissue culture
cells (i.e. murine macrophages) and in primary human
cells (patients with active melioidosis) [44-47]. MNGC
formation has been demonstrated in both phagocytic and
non-phagocytic cells in addition to patient tissue(s) with
active melioidosis [46-54]. The importance of Bp-mediated
MNGC formation during infection is currently un-
known, but it is possible that cell to cell spread via MNGC
allows the pathogen to avoid immune surveillance in vivo.
The Bp genome encodes a diverse range of specialized
protein secretion systems including three type III secre-
tion systems (T3SS) and six type VI secretion systems
(T6SS) [1,55,56]. Mutation of the Bp T3SS-3, which is
homologous to the Shigella Mxi-Spa and Salmonella SPI-
1 T3SSs, results in loss of Bp induced MNGC formation,
inability of endosomal escape and loss of virulence inanimal models of Bp infection [50,53,57]. Likewise, disrup-
tion of components making up the T6SS-1 reduced animal
virulence and hindered MNGC formation in RAW264
macrophages [58]. In addition, it has been shown that the
Bp alternative sigma factor RpoS, which is involved in
genome-wide regulation of bacterial adaptation to environ-
mental stress (i.e. nutrient limitation), plays a role in Bp
induced MNGC formation [59]. Recently, the molecular
mechanism of Bp MNGC formation was revealed by
Toesca et al. [60]. The T6SS-1 valine-glycine repeat tail
spike protein (VgrG1) possesses a novel fusogenic domain
at its C-terminus that mediates cell fusion and allows Bp
cell to cell spread.
Automated high content imaging (HCI) microscopy is a
powerful technique to quantitatively characterize cellular
phenotypes at the single cell level in response to bacterial
and viral infection, exposure to drug agonists and antago-
nists and for drug mechanism of action determination
[61-69]. This work describes the development of a cell-
based HCI immunofluorescence assay to quantitatively
characterize the MNGC phenotype induced in murine
macrophages upon infection with Bp K96243. As a proof
of principle for its applicability in a relevant biological set-
ting, this assay was validated using mutants of Bp that
were previously described to be defective for MNGC for-
mation in mouse macrophages [58,70]. Furthermore, we
used the MNGC HCI assay to screen a focused small mol-
ecule library to identify compounds that interfere with
MNGC formation induced by Bp. Together, the results of
these experiments indicated that the HCI MNGC assay
can be used in a medium-throughput format to identify
and characterize Bp mutants that are defective in their
ability to induce MNGCs and to identify small molecules
that inhibit this phenotype.Results & discussion
Optimization of the MNGC assay
To develop an automated high-throughput method for
quantitating MNGCs, RAW264.7 macrophages were either
not infected (Figure 1A, Top panel-mock) or infected at an
MOI of 30 with wild-type Bp K96243 (Figure 1A, bottom
panel-wild-type Bp). After 2 h excess extracellular bacteria
were then eliminated by sequential washes in PBS and cells
were further incubated in medium containing kanamycin.
At 10 h post-infection macrophages were first fixed, and
then immunofluorescence (IF) staining was performed to
detect bacteria and cellular structures. Finally, samples
were imaged by high-throughput confocal fluorescence mi-
croscopy. Cell nuclei were stained with the DNA dye
Hoechst 33342 and the cell body with the CellMask
DeepRed dye. Bacteria associated with or internalized by
macrophages were detected by staining cells with an anti-
Burkholderia pseudomallei monoclonal antibody.
Figure 1 Quantitative analysis of B. pseudomallei K96243 induced murine macrophage MNGC formation. (A) Representative 20X magnification
confocal images of RAW264.7 macrophages that were not infected (mock) or infected with wild-type B. pseudomallei K96243 at a MOI of 30 at 10 h
post-infection. Images of cell nuclei (stained with the Hoechst 33342 dye), cell cytoplasm (stained with CellMaskDR- CellMask DeepRed) and Bp:
bacteria labeled using an anti-B. pseudomallei mouse monoclonal and a secondary anti-mouse/Alexa488 antibody. Scale bar: 90 μm. (B) Visual representation
of the MNGC Image Analysis procedure. Each object (Nuclei) is pseudocolored with a unique color in the nucleus segmentation panel. Bacterial spots are
pseudocolored in green in the spot segmentation panel. Nuclei clustering: Nuclei are clustered based on distance as described in Experimental procedures
to generate the Cluster population. In the MNGC selection panel, image objects classified as MNGC are pseudocolored in green, and non-MNGC objects are
pseudocolored in red. (C) Histograms representing the quantification of cellular attributes of the cluster population as measured by the MNGC image analysis
procedure described in Figure 1B. (D) Histograms showing the results of the quantification of cellular attributes related to bacterial spot formation. In C and
Dmeans +/− standard deviation (SD) are shown for three independent B. pseudomallei macrophage infections performed on separate days and with six
replicates/plate. n = 18 and > 500 nuclei were analyzed per well. **** p < 0.0001.
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http://www.biomedcentral.com/1471-2180/14/98As observed in the fluorescence microscopy images,
Bp infection induced cell-to-cell fusion, clustering of the
nuclei and cell body enlargement in a substantial frac-
tion of infected macrophages when compared to mockinfected samples (Figure 1A). These cellular objects fit
the definition of MNGC. A large number of Bp bacterial
spots were found to be either internalized or in close
proximity with the boundaries of infected cell bodies. In
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http://www.biomedcentral.com/1471-2180/14/98these experimental conditions not all the infected cells ap-
pear to be part of an MNGC object (Figure 1A). Hence, it
was important to develop an HCI analysis that would
recognize and distinguish MNGC objects from non-
MNGC objects in a heterogeneous population of infected
cells. To address this issue, we took advantage of the close
proximity of the nuclei in MNGC’s to recognize and clas-
sify MNGC clusters. Briefly, and as shown in Figure 1B,
cell nuclei were first identified by using the Hoechst
33342 channel image, thus obtaining a population of ob-
jects that was named “Nuclei”. The cell body edges were
identified by expanding the body of the nucleus detected
in the previous step. The cell body borders were then de-
tected by using the CellMask DeepRed channel image.
Bp spots were identified using the Bp antibody channel
image. Several cellular attributes were calculated for the
Nuclei population, the most relevant being: number of
objects, cell body area and number of bacterial spots per
object. The next step in the image analysis consisted in
recursively clustering distinct Nuclei objects together
into a single “Cluster” object, provided that their nuclei
were either touching or adjacent. All the cellular attributes
of the Nuclei population calculated on a single-object
basis were then summed into the corresponding Cluster
object. In addition, the number of Nuclei per Cluster
(Polynucleation) was calculated. Finally, based on visual
inspection of images analyzed with this strategy, the Clus-
ter population was further classified into either MNGC
(>3 Nuclei per Cluster) or non-MNGC (≤3 Nuclei per
Cluster) sub-populations (Figure 1B). This approach was
then used to quantitatively measure MNGC formation in
RAW264.7 macrophages infected with wild-type Bp
K96243. As seen in Figure 1C, the results of these experi-
ments indicate that the HCI MNGC analysis can be used
at the well level to detect MNGC formation in Bp
K96243-infected populations when compared to mock in-
fected samples. In particular, and as expected, infected
cells had a 4.3-fold increase in Cluster Area, a 2.4-fold in-
crease in Number of Nuclei per Cluster, and a 21-fold in-
crease in the Percentage of MNGC when compared to
non-infected samples.
Single cell analysis of the Bp K96243 infected
macrophages
Quantitation of MNGCs using the image analysis proced-
ure typically outputs statistical descriptors, such as means
and standard deviations, at the well level. While the well
level analysis of MNGC formation provides statistically sig-
nificant differences between mock infected and Bp K96243
infected cells (Figure 1B), we also wanted to determine if
our image analysis approach was capable of distinguishing
MNGCs in heterogeneous populations of infected cells. To
test this, we plotted single-cell data generated by the
MNGC analysis on either mock-infected or Bp K96243infected cells (Figure 2). As expected, using a similar
classification approach to the one described above, we
were able to visually detect an increase in the incidence
of MNGC formation in images from Bp K96243 in-
fected macrophages compared to uninfected macro-
phages (Figure 2A). The percentage of Cluster objects
classified as MNGC (+) increased from 0.52% (mock)
to 6.6% (Bp K96243) (Figure 2B). The presence of a
small percentage of MNGC (+) objects in uninfected
RAW264.7 samples reflects the presence of cell clumps
morphologically unrelated to real MNGC (Figure 2A
and Figure 2B) and constitutes the negative control meas-
urement background in the MNGC analysis. Nevertheless,
as expected, clusters classified as MNGC (+) in Bp K96243
infected samples had larger mean Cluster Area and a larger
mean Number of Spots per Cluster when compared to the
MNGC (−) objects present in the same samples at the 10 h
time point. Accordingly, the higher incidence of MNGC
(+) objects in Bp K96243 infected cells when compared to
mock infected cells led to a shift towards higher values of
Cluster Area and Number of Spots per Cluster in the
single-cell distributions (Figure 2C). Thus, the results of
the MNGC HCI analysis indicate that, at an MOI of 30
and 10 h post Bp K96243 infections, there are at least two
sub-populations of RAW264.7 cells associated with bacter-
ial spots, which are phenotypically dissimilar, both in terms
of cell size and polynucleation (Figure 2B and Figure 2C).
Validation of the MNGC assay to detect mutants defective
in their ability to induce MNGC
Having shown that the HCI MNGC assay is capable of de-
tecting and quantitating Bp induced cell-to-cell fusion, we
then set out to test whether this method could be used to
detect defects in MNGC formation caused by mutations
in Bp genes. It was previously reported that deletion of the
Bp Δhcp1 gene, which is encoded within the cluster 1 type
VI secretion system operon, resulted in a significant in-
crease in the 50% lethal dose in a Syrian hamster model of
infection (103 vs. <10 bacteria), in reduced macrophage
intracellular replication and most notably in the failure to
induce macrophage MNGC formation [58]. Likewise, it
was demonstrated that deletion or inactivation of the Bp
bsaZ gene, which is encoded within the Bp T3SS-3 results
in delayed macrophage vacuolar escape, in reduced intra-
cellular replication at 3, 6, and 12 h and in sporadic
MNGC formation [50]. Thus, in order to test the possibil-
ity of using the HCI MNGC assay to profile Bp mutants,
we analyzed the ability of Bp K96243 and the two isogenic
mutants harboring gene deletions in the Bp T6SS-1
(Δhcp1) and the T3SS-3 (ΔbsaZ) to induce MNGC forma-
tion at two different time points. RAW264.7 macrophages
were not infected (mock), infected with wild-type Bp
K96243 or with the Δhcp1 or ΔbsaZ mutants at a MOI of
30 for 2 h and then processed in IF and HCI as described
Figure 2 Single cell analysis of B. pseudomallei K96243 induced murine macrophage MNGC formation. (A) Representative 20X magnification
confocal images of RAW264.7 macrophages that were not infected (Mock) or infected with wild-type B. pseudomallei K96243 at a MOI of 30 at 10 h
post-infection. CellMask DeepRed –cytoplasmic/nuclear stain. (B) Single cell image cytometry analysis of MNGCs induced in macrophages that were
not infected (Mock; left panel) or infected with wild-type B. pseudomallei K96234 (right panel). Objects classified as MNGC (+) are pseudocolored in red
in the image plots and in the dot plot graphs. (C) Histogram plots showing the distribution of the cluster populations based on the cluster area (left
panel) in macrophages that were uninfected (Mock, black) or infected with wild-type B. pseudomallei K96234 (Wild-type Bp, red); and the number of
bacterial spots associated with each cluster (right panel).
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http://www.biomedcentral.com/1471-2180/14/98above (Figure 3). At the early time point (2 h), infection
with all the three Bp strains led to the appearance of bac-
terial foci either in the cytoplasm or associated with the
cell membrane of RAW264.7 macrophages (Figure 3A).
When quantified with the MNGC analysis pipeline we
could detect significant differences between the Bp K96243
(wt) and the mock infected samples in terms of mean
Number of Spots per Clusters, Cluster Area and marginally
significant differences in terms of mean Percentage of
MNGC (Figure 3B). Bp Δhcp1 had a significantly lower
Number of Spots per Clusters and a significantly lower
total Number of Spots when compared to Bp K96243 (wt)
(Figure 3C). At this time point, Bp ΔbsaZ was indistin-
guishable from Bp K96243 (wt) (Figure 3C). Altogether the
results of these experiments indicate that deletion of bsaZ
has no effect on bacterial adhesion and/or uptake byRAW264.7 cells, while deletion of Δhcp1 has some minor
but significant effects on these processes. Our observed re-
sults for the Bp ΔbsaZ mutant were similar to that re-
ported by French et al. [44]. On the contrary, our findings
with Bp Δhcp1 mutant during this early infection time did
not correlate with those reported [44,58], which may due
to the differences in the experimental conditions such as
MOI, time of infection or the type of Burkholderia strain
used in the studies.
At later stages of the bacterial replication cycle (10 h
post-infection), more significant differences were ob-
served between Bp K96243 (wt) and the mutant strains
(Figure 4). Of note, the bacterial mutants showed more
diffused (Δhcp1) or rounder, reduced and more isolated
spot staining pattern (ΔbsaZ) when compared to Bp
K96243 (wt) (Figure 4A, Bp panels). As expected, Bp
Figure 3 (See legend on next page.)
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Figure 3 Validation of the MNGC assay (2 h post-infection). (A) Representative confocal images of RAW264.7 macrophages infected at 30
MOI with wild-type Bp K96243 (wt), or Bp Δhcp1, or Bp ΔbsaZ respectively. Scale bar: 90 μm. Macrophages were infected with Bp for 2 h and then
fixed, processed in IF and images were acquired and analyzed according to the MNGC analysis script (described in the Methods − Image
acquisition and analysis section and shown in Figure 1B). (B) Bar graphs for the quantification of several cellular features of MNGC formation. (C)
Bar graphs for the quantification of bacterial spots per MNGC cluster and total number of bacterial spots. In B and C means +/− SD are shown of
6 replicates per plate, 3 plates run on independent days (n = 18). For each replicate well >1000 nuclei were analyzed. **** p <0.0001; ** p < 0.01.
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http://www.biomedcentral.com/1471-2180/14/98K96243 (wt) infection strongly induced MNGC forma-
tion, while in this respect both Bp ΔbsaZ and Bp Δhcp1
were defective (Figure 4A, Hoechst and CellMask DR
panels). HCI analysis was used to quantify differences
between Bp K96243 (wt) and the bacterial mutant
strains in their potential to induce the MNGC pheno-
type in infected RAW264.7 macrophages (Figure 4B and
Figure 4C). In these experimental conditions Bp K96243
(wt) induced a 2-fold increase in mean Cluster Area and
mean Number of Nuclei per Cluster and a 4-fold in-
crease in mean Percentage of MNGC when compared to
the negative control (Figure 4B). All these differences
were statistically significant. On the contrary, using the
same experimental conditions, while bacterial spots were
still detected in IF (Mean Total Number of Spots per
well, Figure 4C), Bp Δhcp1 or Bp ΔbsaZ failed to induce
an increase in the mean Cluster Area, Number of Nuclei
per Cluster or Percentage MNGC and were hardly dis-
tinguishable from the uninfected samples (Figure 4B).
Significant differences in the mean number of Spots per
Cluster between Bp K96243 (wt) and Bp Δhcp1 or Bp
ΔbsaZ were observed (Figure 4C) and were probably
due at least in part to an increase in the mean Cluster
Area in Bp K96243 infected samples (see above). The in-
ability to see an increase in the total number of bacterial
spots during the intracellular replication step (10 h post-
infection) compared to early uptake or phagocytosis step
(2 h post-infection) may partly be due to the killing of
the internalized bacteria by the professional phagocytes.
Although bacteria can be detected and quantitated by
HCI, this technique it does not measure bacterial viabil-
ity. Altogether, these results show that the HCI MNGC
assay can be implemented to quantitatively characterize
mutant Bp strains phenotype based on cellular morpho-
logical changes induced in infected host cells. Furthermore,
our HCI results regarding reduced MNGCs and bacterial
spots following infection with Bp Δhcp1 or Bp ΔbsaZ mu-
tants compared to wild type Bp at 10 h post-infection are
consistent with previously published data [44,58].
Screening of a small molecule library in the MNGC assay
To discover possible cellular pathways that are hijacked by
Bp and that might regulate cell-to-cell fusion, we used the
HCI MNGC assay to screen a small, functionally focused
collection of 43 compounds in duplicate. The compounds
in this collection are annotated as targeting pathwaysinvolved in the epigenetic regulation of chromatin (See
Experimental procedures for details). Bacterial infection
induced epigenetic changes such as histone modifications,
DNA methylation, chromatin remodeling, which in turn
affect host cell signaling has been shown to either pro-
mote host defense or increase susceptibility to infection
[71]. To investigate Bp induced epigenetic changes which
in turn may modulate MNGC formation, RAW264.7 mac-
rophages were first pre-treated with the compound library
and then infected with Bp K96243. Cells treated with
DMSO (Vehicle) and infected with Bp K96243 were con-
sidered as negative controls. At 8 h post-infection cells
were fixed and processed in IF for the HCI MNGC assay
as described above. Representative images of macrophages
that were not infected (mock) or infected with Bp K96243
in presence of DMSO or identified hit compounds are
shown in Figure 5A. Compounds were ranked based on
the Z-score for the Percentage of MNGC attribute
(Figure 5B). Compounds with high Z-scores were inhibi-
tors of Bp K96243 induced MNGC formation, whereas
compounds with low Z-scores increased MNGC formation.
Compounds that had a percentage of MNGC Z-score >3
were scored as positive hits. A total of 15 out of the original
43 compounds matched this criterion (Figure 5B). Further-
more, to exclude cytotoxicity as the leading mechanism of
action for MNGC reduction, compounds that had a Num-
ber of Nuclei Z-score < − 3 were not considered for further
analysis. A total of 9 out of the original 15 compounds
passed the cytotoxicity filter (Figure 5B) and were consid-
ered as hits. A total of 7 out of the 9 identified hits belong
to the Histone Deacetylase (HDAC) enzyme inhibitor cat-
egory. Importantly, none of these hit compounds reduced
the total number of Bp spots per well (Data not shown),
ruling out that their mechanism of action involves direct in-
hibition of bacterial adhesion and/or uptake by host cells.
Visual inspection of samples treated with the three HDAC
inhibitors (Scriptaid, Fluoro-SAHA, and M-344) confirmed
that these compounds were not cytotoxic and hence did
not alter the cell number when compared to DMSO
treated samples, but substantially inhibited MNGC for-
mation in their presence. Furthermore, M-344 showed
a dose-dependent inhibition of MNGC formation induced
upon Bp K96243 infection (Figure 5C). Altogether, these
results indicate that the HCI MNGC assay can be used to
screen small molecule libraries for the identification of
compounds that can inhibit MNGC formation and that
Figure 4 (See legend on next page.)
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Figure 4 Validation of the MNGC assay (10 h post-infection). (A) Same as Figure 3A, except that macrophages were fixed at 10 h post-infection
for different strains of Bp. Scale bar: 90 μm. (B) HCI quantification of several cellular features of MNGC formation and (C) bacterial features from images
acquired as described in Figure 3A. In B and C means +/− SD are shown of 6 replicates per plate, 3 plates run on independent days (n = 18). For each
replicate well >1000 nuclei were analyzed. **** p <0.0001; *** p < 0.001.
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regulation of this process.Conclusions
In summary, we have successfully developed an automated
HCI assay to quantitate MNGCs induced by Bp in macro-
phages. This assay was then used to characterize the
phenotype of the Bp mutants for their ability to induce
MNGC formation and identify small molecules that inter-
fere with this process. This assay can also be applied to
identify the molecular targets and mechanisms responsible
for the Bp induced phenotype, which to date are poorly
understood. In addition, this assay has potential application
for characterizing bacterial isolates as well as the identifica-
tion of immune modulators such as cytokines that induce
or inhibit this phenotype. Currently, we are not aware of a
robust and direct HCI method to unambiguously distin-
guish cell clumps from MNGC. Nevertheless, in the
experimental conditions described in the manuscript, and
in the absence of tested compounds, the detection of
MNGC via our HCI method is clearly dependent on infec-
tion by Bp (Figures 1, 4 and 5). Compounds that induce
cell clumping rather than MNGC-formation might be
counter-screened by measuring MNGC formation in mock
infected/compound treated cells. In addition, it will be of
future interest to develop and implement calculated cellu-
lar attributes (such as Cell Area) or the IF staining of
additional cellular structures (such as Actin or Tubulin) to
further refine and improve the HCI analysis of MNGC.Experimental procedures
Bacterial propagation
Burkholderia pseudomallei K96243 was maintained in ei-
ther Luria-Bertani (LB) broth, on LB plates or on 1.5%
agar plates containing 5% sheep blood (SBA). Broth cul-
tures were grown at 37°C with shaking at 250 rpm and
agar plates were incubated at 37°C. For macrophage infec-
tions, Bp was grown on LB plates for ~18 h at 37°C and a
loopful of the culture was suspended in 10 ml of Dulbec-
co's Modified Eagle Medium (DMEM) (Gibco, Carlsbad,
CA). Bacterial concentrations were determined by meas-
uring the OD600 and cell suspensions were adjusted to a
multiplicity of infection (MOI) of 30 using a conversion
factor of 5 × 108 CFU/ml per unit of optical density at
600 nm [72]. All Bp manipulations were performed in
biosafety level 3 laboratories.Construction of a B. pseudomallei ΔbsaZ type three
secretion mutant
Genomic DNA from Bp ΔsctUBp3 [70] was purified [73]
and used as template DNA for PCR amplification of the
ΔbsaZ gene. Gene amplification was performed using the
forward primer bsaZ-FXb 5’-CATGTCTAGACTTCACGT
CACGTCATGCCGAGCGACACG-3’ and reverse primer
bsaZ-RH 5’-CATGAAGCTTTGTTGGCTAGTGGTCGTT
CCC-3’ with the Epicentre FailSafe Kit with buffer “D” (Epi-
centre Technologies, Madison, WI) using the following con-
ditions: one cycle at 94°C for 5 min; 30 cycles at 94°C for
30 sec, 56°C for 30 sec, and 72°C for 1 min; followed by a
final 7 min extension at 72°C. Characters in boldface in the
above primer pair represents the XbaI and HindIII sites in-
corporated into the oligonucleotides for directional cloning.
PCR products were resolved on a 2% agarose gel and ex-
cised using the GeneClean III kit (Qbiogene, Carlsbad,
California). Purified PCR fragments were digested with XbaI
and HindIII (New England Biolabs, Ipswich, MA) using buf-
fer “2”, cleaned as described above and cloned into the simi-
larly digested sacB-based suicide plasmid pMo130 [74] to
generate pMoΔbsaZ. Ligations were transformed into
chemically competent Escherichia coli TOP10 (Invitrogen,
Carlsbad, CA) and recombinant plasmids were purified
using the Wizard Plus SV miniprep kit (Promega, Madison,
WI). pMoΔbsaZ was electroporated into E. coli S17-1 and
mobilized into Bp K96243 as previously described [75,76].
pMoΔbsaZ was resolved from transconjugants by culturing
the isolates in LB without NaCl containing 10% (wt/vol) su-
crose for 3–4 days at 25°C. Deletion of the Bp bsaZ gene
was confirmed using PCR and apparent by a reduction in
the amplicon size of ~1060 bp.
Tissue culture and macrophage infections
The RAW264.7 cell line was maintained in DMEM
(Gibco) containing 10% FBS (Hyclone, Logan, UT), 1%
non-essential amino acids (Sigma, St. Louis, MO), 1%
HEPES buffer (Gibco) and 1% L-Glutamine at 37°C
under an atmosphere of 5% CO2. For macrophage infec-
tions, BD Falcon 96-well plates (Franklin Lakes, NJ)
were seeded with ~2 × 104 cells/per well and incubated
overnight as described above to obtain ~4 × 104 cells/
well. Macrophages were infected with Bp at a MOI of 30
(or otherwise noted) for 2 h, monolayers washed three
times with PBS to remove extracellular bacteria and ei-
ther macrophages were fixed (2 h infection) or pre-
warmed DMEM containing 10% fetal bovine serum and
250 μg/ml of kanamycin (Sigma) was added to reduce
Figure 5 (See legend on next page.)
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Figure 5 Screening of focused small molecule library for inhibitors of MNGC formation. RAW264.7 macrophages were pretreated for 2 h
with a collection of 43 compounds active against enzymes involved in epigenetics regulation at a concentration of 20 μM and then infected with
30 MOI of Bp K96243 for 8 h. Cells were fixed, stained in IF and imaged as described above. The effect of the tested compounds on MNGC
formation was quantified. Compounds were ranked based on the potency of MNGC inhibition when compared to DMSO-treated, Bp K96243-
infected samples (Negative control). Cytotoxic (Number of Nuclei Z-score < −3) were not further considered. (A) Representative confocal images
of macrophages pre-treated with DMSO control or primary hit compounds active in the MNGC screen. Scale bar: 90 μm. (B) Compounds that
significantly reduced the number of MNGC when compared to DMSO treated samples (% MNGC Z-score > 3) were scored as positive hits
(red bars). Bars represent means from two replicates. (C) Dose-dependent inhibition of MNGC formation by compound M-344 identified in the
primary screen.
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for an additional 8 h (or otherwise noted) and mono-
layers were fixed for ~18-24 h with 10% formalin prior
to antibody staining.
Macrophage and bacterial staining
Following macrophage fixation cells were washed and
subsequently permeabilized for 15 minutes at room
temperature with Cellomics 1× permeabilization buffer
(Halethorpe, MD), washed twice with PBS and blocked
(minimum of 1 h) with Cellomics 1x blocking buffer.
Following incubation, blocking buffer was removed and
replaced with 50 μL of a 1:1000 dilution of 2 mg/mL
anti-Burkholderia pseudomallei monoclonal antibody
(AB-BURK-P-MAB3, Critical Reagents Program, Frederick,
MD) for 1 h. Unbound primary antibody was removed by
two washes with PBS and a 1:500 dilution of Dylight 488
goat anti-mouse secondary antibody (Fisher Scientific,
Waltham, MA) was added at room temperature for 30 min.
Cells were washed two additional times with PBS and 1×
CellMask DeepRed (Invitrogen) and 1:10,000 Hoechst nu-
clear stain (Invitrogen, Carlsbad, CA) were added.
Image acquisition and analysis
An Opera QEHS confocal system (PerkinElmer, Waltham,
MA) was used for high-throughput image acquisition. 4
imaging fields per well were acquired with a 20X water
objective in the Blue (Hoechst 33342), Green (Alexa488)
and Far Red (CellMask DeepRed) channels on a single Z-
plane in 2 sequential exposures. The first exposure utilized
the 488 nm and 640 nm excitation lasers, the emitted light
was first filtered by a 405/488/640 primary dichroic
mirror, then collected on separate high resolution CCD
cameras through 525/35 nm and 690/70 nm band pass
filters, respectively. The second exposure used the 405 nm
and the excitation light was filtered first through a 405/
561/640 primary dichroic mirror, then through a 568 nm
Detection dichroic mirror and finally through a 450/
50 nm band pass filters. Images were imported into
Columbus 2.3 database (PerkinElmer) and analyzed with
Acapella 2.7 (PerkinElmer). For the MNGC assay, nuclei
were first identified using the Hoechst33342 channel
image as input, then the cell edges were determined using
the CellMask DeepRed channel image, and bacterial spotswere detected using the Alexa 488 channel image. The nu-
clei detection described above generated a first population
of objects (Nuclei), for which cellular attributes were calcu-
lated (Cell Area, Number of Foci per Cell). Nuclei objects
were then clustered together based on the distance of their
nuclear bodies (Measured in pixels). Nuclei objects whose
nuclear bodies were within a distance of 0 or 1 pixels,
depending on the experiment, were considered as part of a
single Cluster object. All the cellular attributes of the
Nuclei population were then imported (As sums) into the
corresponding Clusters and the number of Nuclei per
Cluster attribute was also calculated. Clusters were then
further classified into a MNGC subpopulation based on
the number of nuclei present in the cluster (Nuclei per
Cluster >3). The Percentage of MNGC was calculated
as (Number of MNGC objects)/(Number of Cluster
objects)*100. Values in the histograms represent the
mean +/SD of 6 replicates on the same plate run on 3
separate days (n = 18). Statistical significance for differ-
ences in cellular and bacterial attributes between differ-
ent samples was calculated using the t-test. For single
cell analysis presented in Figure 2, images were directly
analyzed after image acquisition with Acapella 2.6,
(Using an image analysis strategy similar to the one just
described above, Nuclear distance for clustering: 3 pixels)
and the image analysis results were imported into FCSEx-
press4 (Denovo Software, Los Angeles, CA), which was
used for single cell image cytometry measurements.
Small molecule screening in the MNGC assay
RAW264.7 macrophages were seeded as described above.
Cells were pre-incubated for 2 h at a final concentration
of 20 μM with a collection of 43 compounds selected for
their activity on enzymes involved in regulation of chro-
matin function (Screen-Well Epigenetics Library, version
1.0, Enzo Life Sciences). Cells were then infected with 30
MOI of wild-type Bp K96243. Cells treated with DMSO
and infected with Bp K96243 were considered as the nega-
tive control; whereas DMSO-treated, mock infected cells
were considered as the positive control. Two hours post-
infection monolayers were washed three times with PBS
to remove extracellular bacteria and pre-warmed DMEM
containing 10% fetal bovine serum, the chemical com-
pounds under testing and 250 μg/ml of kanamycin
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growth. Infections were continued for an additional 6 h
and monolayers were fixed for ~18-24 h with 10% forma-
lin prior to antibody staining. Cells were IF stained and
confocal images were acquired as described above. The
MNGC HCI analysis procedure was used to calculate the
number of nuclei and the percentage of MNGC. The Z-





Where: Z-Scoreij = Z-Score for well in Row “i” and
Column “j”, % Sampleij = Cellular attribute value for well
in Row “i” and Column “j”, μN=Mean of the Cellular at-
tribute for the negative controls on the plate, and σS =
Standard Deviation of Cellular attribute for the negative
controls on the plate. Compounds that had both Num-
ber of Nuclei Z-Scoreij > −3 (Cytotoxicity filter) and %
MNGC Z-Scoreij > 3 (Activity filter) were considered as
active compounds.
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